Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.
about
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer developmentCoordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomasMYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical managementNoncoding RNA in oncogenesis: a new era of identifying key playersMYC and the art of microRNA maintenanceCombating the epigenome: epigenetic drugs against non-Hodgkin's lymphomac-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignanciesRecent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium Workshop.Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches.Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma.Histone deacetylase 1/Sp1/microRNA-200b signaling accounts for maintenance of cancer stem-like cells in human lung adenocarcinomaEpigenetic alteration and microRNA dysregulation in cancerMicroRNA-16 is down-regulated in mutated FLT3 expressing murine myeloid FDC-P1 cells and interacts with Pim-1.Role of microRNAs on therapy resistance in Non-Hodgkin's lymphoma.Polycomb genes, miRNA, and their deregulation in B-cell malignanciesHypoxia-induced miR-15a promotes mesenchymal ablation and adaptation to hypoxia during lung development in chicken.Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo.miR-335 Targets SIAH2 and Confers Sensitivity to Anti-Cancer Drugs by Increasing the Expression of HDAC3.c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell LineCDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.Dysregulated post-transcriptional control of COX-2 gene expression in gestational diabetic endothelial cellsTumor necrosis factor-related apoptosis-inducing ligand induces the expression of proinflammatory cytokines in macrophages and re-educates tumor-associated macrophages to an antitumor phenotypeMicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders.Mechanisms of epigenetic deregulation in lymphoid neoplasms.High blood sugar levels significantly impact the prognosis of colorectal cancer patients through down-regulation of microRNA-16 by targeting Myb and VEGFR2.A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas.Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.Regulation of microRNAs by epigenetics and their interplay involved in cancer.microRNAs are biomarkers of oncogenic human papillomavirus infections.Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer.Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.MicroRNAs and lymphomagenesis: a functional review.MicroRNAs in mantle cell lymphoma.MYCN-mediated transcriptional repression in neuroblastoma: the other side of the coin.Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs.Challenges and opportunities of microRNAs in lymphomas.miRNA-15a/16: as tumor suppressors and more.Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review.
P2860
Q22000752-10279647-AA24-448B-ABAB-FB0C5FDC3277Q24301269-CE416356-98CF-47EA-BA7C-E5BDD4771559Q26785379-73B0E25E-378C-40A1-8DAC-15767CC3C62DQ26823718-8277E4A7-0E95-4F98-8ECF-76D195250F93Q26825457-A9642D5E-46F4-4E47-98E5-E0E9851348CCQ26851166-640A131E-6915-4C00-9A16-D21F621DD3D1Q26851373-5E8452B7-CE9A-4E4C-9116-B4C059B1995EQ30456436-166AE2CF-9026-48B1-A361-2C7C4EF00AD3Q33586239-B7342F0E-1389-461B-8A11-D373CEA64186Q33586491-E5807C81-A5B7-45D2-83F9-25ADC82CC3C6Q33587128-B772253C-288F-4F27-9B84-1537E4375D3CQ34287415-652739A9-02AB-4889-9291-833A47DB5807Q34392645-BE139955-3C37-46DC-87EC-9A54E24979DCQ34412520-5630A0B8-6B9D-4344-90F0-82BCC24A7667Q34769735-F952AC9C-55D4-46C7-8323-1EB5924BC0C8Q35103527-253B3E11-7B88-481F-8574-0F5ECD0BB7E5Q35179724-C5D28A2C-7C64-408C-B85A-06FD0A1056E3Q35741591-EC04A914-8E20-4422-B2E9-506B9291ACE7Q35749739-A6F5B51E-35D5-49A9-9D8D-46B376F3C26DQ35783276-1A841F49-D000-4EBE-8C7B-83B42F46EB6FQ35963331-DD9D2FEB-16C6-4C1E-84D3-FD790CB764AAQ36036258-E04578B4-18AE-4106-A997-EBA16656A675Q36058434-6B0B4458-4987-4CDA-971F-F49E3558772AQ36422143-6327FD3F-5151-440B-95B4-FA88F074C41BQ36873265-A697DD63-8BF0-4146-8F78-5A537A35F69EQ37109882-4A123943-5C40-4A26-A5E5-FC9DEC4EA78AQ37259187-6496817B-2A6E-447B-BC98-A328BE712D31Q37293498-28FDC496-F439-43BD-B0EF-ADB6C3149F45Q37418150-510836B5-8BDC-422F-8825-B58767971871Q37659973-24D1372B-1AEF-411B-8DA2-C8744855A9D1Q37694670-A18F0994-CE44-4C69-8F8F-5C54AC578C7AQ37702571-0FD1D33D-1D70-46A1-8078-0F555919B43FQ37718379-0D902A74-F2EC-4492-86A4-0088F644B5DAQ38064494-12F914B6-627A-4911-AC8E-BB4518F7DDE5Q38075896-F02E1CCC-A4BB-4FA2-9F25-0083BD260342Q38088637-BFE11306-9130-47C5-A684-8EAE6B54249EQ38153384-FEE91621-249C-4DF1-9A7C-28C4C2548A9DQ38251994-687A61D7-73DB-453B-92F3-2278AFAD3397Q38564093-1E5D2C00-88B7-40C7-AEFB-FFAE8B06FA40Q38572855-76E6B4E5-5FC7-4E00-A8F1-297CF2833598
P2860
Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Myc represses miR-15a/miR-16-1 ...... non-Hodgkin B-cell lymphomas.
@en
Myc represses miR-15a/miR-16-1 ...... non-Hodgkin B-cell lymphomas.
@nl
type
label
Myc represses miR-15a/miR-16-1 ...... non-Hodgkin B-cell lymphomas.
@en
Myc represses miR-15a/miR-16-1 ...... non-Hodgkin B-cell lymphomas.
@nl
prefLabel
Myc represses miR-15a/miR-16-1 ...... non-Hodgkin B-cell lymphomas.
@en
Myc represses miR-15a/miR-16-1 ...... non-Hodgkin B-cell lymphomas.
@nl
P2093
P2860
P356
P1433
P1476
Myc represses miR-15a/miR-16-1 ...... non-Hodgkin B-cell lymphomas.
@en
P2093
E Sotomayor
L C Moscinski
W S Dalton
P2860
P2888
P304
P356
10.1038/ONC.2011.470
P407
P577
2011-10-17T00:00:00Z